NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,820,548 | -36.8% | 116,047 | -37.3% | 0.23% | -38.7% |
| Q2 2023 | $18,691,156 | +7.1% | 185,226 | -2.3% | 0.38% | +1.9% |
| Q1 2023 | $17,447,892 | +933.4% | 189,651 | +919.0% | 0.37% | +687.2% |
| Q4 2022 | $1,688,390 | -88.8% | 18,611 | -90.6% | 0.05% | -88.1% |
| Q3 2022 | $15,089,000 | -17.0% | 198,515 | -7.7% | 0.40% | -11.0% |
| Q2 2022 | $18,178,000 | -16.1% | 215,050 | -12.9% | 0.44% | -4.3% |
| Q1 2022 | $21,676,000 | +10.3% | 247,016 | +9.9% | 0.46% | +8.2% |
| Q4 2021 | $19,652,000 | -0.8% | 224,666 | -7.3% | 0.43% | -0.2% |
| Q3 2021 | $19,811,000 | -7.9% | 242,252 | +2.7% | 0.43% | -10.0% |
| Q2 2021 | $21,517,000 | +13.0% | 235,822 | +7.8% | 0.48% | +6.0% |
| Q1 2021 | $19,038,000 | +44.5% | 218,770 | +56.7% | 0.45% | +33.0% |
| Q4 2020 | $13,174,000 | – | 139,611 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |